
Portfolio Highlight
Elitone: Expanding Access to Practical, Non-Invasive Women's Health Solutions
Many of the most interesting healthcare businesses address problems that are common, meaningful, and historically underserved by traditional care pathways. Women's health is full of such opportunities. Important conditions affecting comfort, confidence, and daily life have often been under-discussed, underdiagnosed, or served through care models that were inconvenient or incomplete. When a company offers a practical, patient-centered solution in one of these areas, it can create value by meeting a need the system has not fully respected.
Elitone reflects that kind of opportunity. The company provides a non-invasive therapeutic device in women's health, delivering clinically grounded treatment in an at-home format. That matters because patient behavior in this category is shaped not only by clinical need, but also by privacy, convenience, stigma, and the willingness to engage with treatment consistently. Companies that reduce friction and bring care closer to the patient often unlock a larger and more durable market than those that rely entirely on traditional facility-based pathways.
At Totipotent, we are drawn to businesses that understand how people actually seek care. Elitone fits that philosophy. It brings treatment into a setting that can be easier to access and easier to incorporate into day-to-day life. In healthcare, convenience is not a superficial feature. It can directly affect adherence, satisfaction, and the likelihood that a real need will be addressed rather than ignored. In categories where many people have long lived with under-treated symptoms, this can be especially important.
The company also aligns with our interest in underbuilt markets. Women's health has often suffered from a mismatch between the scale of demand and the seriousness of investment attention. Businesses that combine good product design, user empathy, and commercialization discipline can therefore create meaningful value in spaces the market has historically overlooked. Elitone reflects that broader thesis: solve a real problem in a way that is both clinically credible and practically adoptable.
From an investment perspective, companies like Elitone are compelling because they sit at the intersection of patient relevance, commercial opportunity, and category change. They benefit not only from unmet need, but from the broader shift toward more accessible and user-centered healthcare. As patients expect solutions that fit more naturally into daily life, well-designed products in women's health may become increasingly important.
Elitone belongs in our portfolio because it represents the kind of healthcare business we like to back: one that meets a significant need with practicality, seriousness, and empathy. It shows that meaningful innovation is not only about highly technical platforms or large institutional systems. It can also come from serving real people more effectively in categories that have long deserved better solutions.
Why We Invested Elitone
We invested in Elitone because it addresses a meaningful women's health need with a practical, non-invasive solution that fits how people actually engage with care. We are drawn to categories where demand is large but historical market attention has lagged. Women's health remains one of those areas, and companies that combine clinical grounding with usability can build strong positions. Elitone also fits our preference for businesses that reduce barriers to adoption. An at-home, patient-friendly approach matters in categories shaped by privacy, convenience, and under-treatment. We believe the company is positioned in a market where better product design and category seriousness can create real commercial and patient value.

